AGPU AGPU Drug Discovery Services — D&A

Other segment segments

Similar metrics at other companies

FLGTLaboratory Services — D&A

$5.86M+1.8%

AMP

AMPHPharmaceutical Products — D&A

$14.35M+5.4%

CWCOServices — D&A

$64.65K-58.5%

OPKPharmaceutical — D&A

$18.26M+2.7%

WNCParts & Services — D&A

$2.31M+96.6%

CAHPharmaceutical and Specialty Solutions — D&A

$70M+59.1%

Questions, answered.

What is AGPU's drug discovery services — D&A?

AGPU (AGPU) reported drug discovery services — D&A of $26.63K in Q1 2026.

How has AGPU's drug discovery services — D&A changed year-over-year?

AGPU's drug discovery services — D&A decreased by 78.0% year-over-year, from $121.26K to $26.63K.

What does drug discovery services — D&A mean?

Reflects the non-cash allocation of the cost of tangible and intangible assets over their useful lives within the Drug Discovery Services segment. This metric helps investors understand the capital consumption rate of the segment's infrastructure and proprietary technology. It is essential for calculating EBITDA and assessing the segment's true operational cash flow.